Page last updated: 2024-12-05

1,1,1,2-tetrachloroethane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,1,1,2-Tetrachloroethane (also known as 1,1,1,2-TeCA or TCA) is a colorless, volatile liquid with a sweet, chloroform-like odor.

**Importance in Research:**

1,1,1,2-Tetrachloroethane is **not** a commonly used research chemical and doesn't have widespread importance in scientific fields. It is **not** known for any specific biological or chemical properties that would make it particularly valuable for research.

**Why it might be mentioned in research:**

* **Historical context:** It might be mentioned in older literature due to its past use as a **solvent and industrial chemical**. However, due to its toxicity, it is no longer widely used in these applications.
* **Environmental studies:** Due to its previous industrial use, it might be a **contaminant in environmental samples**. Researchers may analyze it to study environmental pollution and its potential impact on ecosystems.
* **Toxicological studies:** It could be used in **limited toxicological studies** to understand its effects on organisms. However, these studies would be conducted under strict safety protocols and with appropriate ethical considerations.

**Important Note:**

1,1,1,2-Tetrachloroethane is **highly toxic** and should be handled with extreme caution. Exposure to it can cause serious health problems, including liver damage, respiratory issues, and even death. It is crucial to avoid contact with this chemical and to handle it only under strict laboratory conditions and with proper personal protective equipment.

**Alternatives:**

If you are looking for a chemical with similar properties but less toxicity, it is important to consult with experts in your field to find suitable alternatives. Many safe and effective solvents are available for various research applications.

1,1,1,2-tetrachloroethane: see also record for tetrachloroethane [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID12418
CHEMBL ID155816
CHEBI ID34024
SCHEMBL ID2565
MeSH IDM0098539

Synonyms (50)

Synonym
BIDD:ER0593
1,1,1,2-tetrachlorethane
CHEBI:34024 ,
1,1,1,2-tetrachloraethan
inchi=1/c2h2cl4/c3-1-2(4,5)6/h1h
1,1,1,2-tetrachloroethane
ethane, 1,1,1,2-tetrachloro-
630-20-6
nci-c52459
einecs 211-135-1
rcra waste number u208
brn 1733216
rcra waste no. u208
tetrachloroethane, 1,1,1,2-
ccris 577
hsdb 4148
CHEMBL155816
1,1,1,2-tetrachloro-ethane
S0647
T0695
NCGC00248924-01
alpha,beta,beta,beta-tetrachloroethyl
ethyl, 1,2,2,2-tetrachloro-
23425-39-0
cas-630-20-6
NCGC00258661-01
dtxsid2021317 ,
dtxcid801317
tox21_201109
AKOS006228374
25322-20-7
4-01-00-00143 (beilstein handbook reference)
0s5mke574x ,
unii-0s5mke574x
SCHEMBL2565
1,1,1,2-tetrachloroethane [hsdb]
hcc 130a
1,1,1,2-tetrachloroethane [iarc]
f 130a
(chloromethyl)trichloromethane
ch2clccl3
mfcd00000807
1,1,1,2-tetrachloroethane, analytical standard
1,1,1,2-tetrachloroethane, reagentplus(r), 99%
1,1,1,2-tetrachloroethane 100 microg/ml in methanol
FT-0750803
Q161264
D92380
contest group c full
25 - vocs in soil
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
chloroethanesA chloroalkane that is ethane in which one or more of the hydrogens is replaced by chlorine.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency28.36460.006038.004119,952.5996AID1159521
SMAD family member 2Homo sapiens (human)Potency64.08130.173734.304761.8120AID1346859
SMAD family member 3Homo sapiens (human)Potency64.08130.173734.304761.8120AID1346859
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency31.82560.000323.4451159.6830AID743065
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID433903Hepatotoxicity in mouse assessed as carcinogenic potency2009European journal of medicinal chemistry, Sep, Volume: 44, Issue:9
Development of QSAR models for predicting hepatocarcinogenic toxicity of chemicals.
AID19825Partition coefficient (logP)1995Journal of medicinal chemistry, Feb-17, Volume: 38, Issue:4
Molecular similarity matrices and quantitative structure-activity relationships: a case study with methodological implications.
AID37562Induction of aneuploidy in Aspergillus nidulans.1995Journal of medicinal chemistry, Feb-17, Volume: 38, Issue:4
Molecular similarity matrices and quantitative structure-activity relationships: a case study with methodological implications.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (26.67)18.7374
1990's3 (20.00)18.2507
2000's4 (26.67)29.6817
2010's4 (26.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 47.90

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index47.90 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.46 (4.65)
Search Engine Demand Index70.70 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (47.90)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (13.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (86.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]